Medicine Man Technologies, Inc. (SHWZ) Income Statement Analysis

See more : Zuger Kantonalbank (ZUGER.SW) Income Statement Analysis – Financial Results

Complete financial analysis of Medicine Man Technologies, Inc. (SHWZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicine Man Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.

You may be interested

Compagnie des Tramways de Rouen (MLTRA.PA) Income Statement Analysis – Financial Results
Lynx Global Digital Finance Corporation (LYNX.CN) Income Statement Analysis – Financial Results
I-PEX Inc. (6640.T) Income Statement Analysis – Financial Results
Sterling Metals Corp. (SAG.V) Income Statement Analysis – Financial Results
Wyld Networks AB (publ) (WYLD.ST) Income Statement Analysis – Financial Results

Medicine Man Technologies, Inc. (SHWZ)

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Website: https://www.schwazze.com

About Medicine Man Technologies, Inc.

Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	172.45M	159.38M	108.42M	24.00M	10.62M	7.92M	3.53M	631.46K	835.78K	251.89K
Cost of Revenue	96.42M	74.35M	59.07M	17.23M	7.62M	2.58M	1.30M	462.18K	209.75K	72.00K
Gross Profit	76.02M	85.03M	49.35M	6.77M	3.00M	5.35M	2.23M	169.27K	626.03K	179.89K
Gross Profit Ratio	44.09%	53.35%	45.52%	28.23%	28.27%	67.47%	63.10%	26.81%	74.90%	71.42%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	70.93M	64.16M	38.94M	29.68M	16.47M	4.40M	7.13M	1.01M	519.88K	193.15K
Selling & Marketing	0.00	-34.77M	0.00	0.00	0.00	291.71K	183.78K	311.52K	16.00K	15.50K
SG&A	70.93M	64.16M	38.94M	29.68M	16.47M	4.69M	7.31M	1.32M	535.88K	208.64K
Other Expenses	1.80M	24.14K	22.33M	32.62K	11.99M	1.37M	-70.04K	165.02K	0.00	0.00
Operating Expenses	72.73M	64.16M	38.94M	29.68M	16.47M	4.69M	7.31M	1.32M	535.88K	208.64K
Cost & Expenses	169.16M	138.51M	98.01M	46.90M	24.08M	7.27M	8.62M	1.78M	745.62K	280.64K
Interest Income	0.00	30.14M	7.01M	41.46K	31.91K	30.00K	30.00K	14.02K	8.07K	3.12K
Interest Expense	32.07M	30.14M	7.01M	41.46K	192.11K	0.00	86.02K	125.16K	0.00	1.18K
Depreciation & Amortization	20.93M	11.55M	8.58M	476.59K	61.71K	81.96K	63.74K	17.37K	6.62K	561.00
EBITDA	37.52M	38.12M	3.47M	-19.80M	-13.55M	1.61M	-5.23M	-1.42M	96.77K	-30.40K
EBITDA Ratio	21.76%	20.02%	3.20%	-104.26%	-89.16%	9.64%	-143.42%	-177.48%	11.58%	-9.95%
Operating Income	3.29M	20.89M	-5.11M	-22.90M	-13.46M	2.17M	-5.24M	-1.15M	90.15K	-28.75K
Operating Income Ratio	1.91%	13.11%	-4.71%	-95.43%	-126.80%	27.39%	-148.34%	-182.45%	10.79%	-11.41%
Total Other Income/Expenses	-18.10M	-16.42M	8.51M	2.59M	-476.76K	-638.50K	-145.22K	-312.18K	8.07K	1.94K
Income Before Tax	-14.81M	-3.57M	18.92M	-20.32M	-17.56M	1.53M	-5.38M	-1.46M	98.22K	-26.81K
Income Before Tax Ratio	-8.59%	-2.24%	17.45%	-84.65%	-165.36%	19.33%	-152.46%	-231.89%	11.75%	-10.64%
Income Tax Expense	19.74M	14.90M	4.40M	-899.11K	-582.93K	582.93K	15.98K	125.16K	12.48K	3.14K
Net Income	-34.55M	-18.47M	14.52M	-19.42M	-16.98M	948.92K	-5.38M	-1.46M	85.75K	-29.95K
Net Income Ratio	-20.03%	-11.59%	13.39%	-80.90%	-159.87%	11.97%	-152.46%	-231.89%	10.26%	-11.89%
EPS	-0.26	-0.34	0.17	-0.47	-0.50	0.03	-0.23	-0.14	0.01	0.00
EPS Diluted	-0.26	-0.34	-0.06	-0.47	-0.50	0.03	-0.23	-0.14	0.01	0.00
Weighted Avg Shares Out	64.54M	53.64M	43.34M	41.22M	33.74M	27.77M	22.99M	10.23M	9.91M	9.84M
Weighted Avg Shares Out (Dil)	64.54M	53.64M	101.37M	41.22M	33.74M	27.77M	22.99M	10.23M	9.91M	9.97M

Buying Into A Down Market (Podcast Transcript)

June 16, 2022seekingalpha.com

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing.

Schwazze: Unexpected Opportunity For Astute Cannabis Investors

May 23, 2022seekingalpha.com

Schwazze is a small, new cannabis company with operations in Colorado and New Mexico. The latest quarterly report showed an unexpected loss and caused a significant decline in the stock price.

Medicine Man Technologies, Inc. (SHWZ) CEO Justin Dye on Q1 2022 Results - Earnings Call Transcript

May 16, 2022seekingalpha.com

Start Time: 16:30 January 1, 0000 5:24 PM ET Medicine Man Technologies, Inc. (OTCQX:SHWZ) Q1 2022 Earnings Conference Call May 16, 2022, 16:30 PM ET Company Participants Justin Dye - Chairman and CEO Nancy Huber - CFO Nirup Krishnamurthy -...

SCHWAZZE TO HOST FIRST QUARTER CONFERENCE CALL & WEBCAST MAY 16, 2022

May 9, 2022prnewswire.com

OTCQX: SHWZ NEO: SHWZ DENVER , May 9, 2022 /PRNewswire/ - Schwazze, (OTCQX: SHWZ) (NEO:SHWZ) ("Schwazze" or the "Company"), announces that it will host a first quarter 2022 conference call and webcast on May 16, 2022 at 4:30 pm EDT. Investors and stakeholders...

Schwazze Announces Virtual Town Hall Meeting

April 25, 2022prnewswire.com

OTCQX: SHWZ NEO: SHWZ DENVER, Colo. , April 25, 2022 /PRNewswire/ - Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), is pleased to announce that Justin Dye, Chairman & CEO will present to investors in a live VID Forum Town Hall on...

Schwazze Remains One Of Top Growth Names Despite Conservative Guide

April 20, 2022seekingalpha.com

Schwazze remains one of fastest revenue growers in US cannabis. Expect growth to continue while scaling profits will come with scale and vertical integration in CO. Believe 2022 guidance could prove conservative as year progresses.

Schwazze: The Best Cannabis Company You Never Heard Of

April 19, 2022seekingalpha.com

Schwazze is a young, fast-growing cannabis company focused on Colorado and New Mexico. Management has a history of turning average businesses into superior businesses.

SCHWAZZE ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES & EVENTS

April 11, 2022prnewswire.com

OTCQX: SHWZ NEO: SHWZ DENVER , April 11, 2022 /PRNewswire/ - Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), is pleased to announce that Justin Dye, Chairman & CEO and Nancy Huber, CFO will participate in the following conferences and events. Cantor Fitzgerald 2nd Annual...